Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 5-HT7 receptor is a G protein-coupled receptor activated by serotonin (5-HT). It is widely expressed in the central nervous system and peripheral tissues, mediating diverse physiological functions including thermoregulation, circadian rhythms, learning, and gastrointestinal motility. It is implicated as a therapeutic target for several disorders, including depression, schizophrenia, irritable bowel syndrome, and circadian rhythm disorders. Activation results in increased cAMP levels. No selective drugs targeting only this subtype are currently approved for clinical use.
Activation by serotonin leads to Gs protein activation, increasing intracellular cAMP levels. Antagonists block serotonin binding, preventing cAMP increase.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-HT7 Receptor (5-HT7).